Exclusive CEO Breakfast Club Series Sponsor
Friday, February 15
The Lambs Club
132 W 44th St, NYC
Breakfast with . . . . .
Sam Waksal, PhD
Dr. Waksal is founder and chief executive officer of Kadmon Corporation. Dr. Waksal is the founder and former President and CEO of ImClone Systems (sold to Eli Lilly & Co. in 2008 for $6.5 billion), developer of Erbitux®, one of the top-selling cancer drugs in the world.
ABOUT THE BREAKFAST CLUB
The NYBA CEO Breakfast Club is an intimate, bi-monthly breakfast and networking event headlined by some of New York’s leading life science entrepreneurs and investors.
Limited to 25 attendees, the Breakfast Club is restricted to life science executives (no service providers beyond the sponsor) and will offer a unique opportunity to hear directly from-and to network with—New York’s life science leadership.
Agenda: 7:30-8:00 am Registration
8:00-8:30 am Breakfast and networking
8:30-9:15 am Speaker program
9:15-9:30 am Q&A and closing
- April 10, 2013: Barbara Dalton, PhD, Vice President, Pfizer Ventures (confirmed)
- June 14, 2013: Robert Nowinski, PhD, CEO, ContraFect and founder of 7 biotech companies including Genetic Systems, PathoGenesis, and Icos (confirmed)
- October 8, 2013: Colin Goddard, PhD, CEO, Coferon and former CEO OSI Pharmaceuticals (confirmed)
- Other great speakers to be announced soon. (August, December)!
Register only for Breakfast with Sam Waksal for $50 (NYBA member rate)
SAVE $ by registering for the entire 6-breakfast series for $280.
PLEASE NOTE: Attendance to CEO Breakfast Club events is restricted to life science executives--registrations from service providers and vendors, including CROs and related service companies, will be declined.